The Vetr community on Wednesday Upgraded Pfizer, Inc. PFE from 3 stars (Hold) to 3.5 stars (Buy). The Vetr crowd was extremely bullish on Pfizer, with 100 percent of Vetr users giving the stock a Buy rating.
See how crowdsourced ratings could help you time the market
At the time of publication, Pfizer shares traded at $35.63. The Vetr crowd was still strongly bullish in the long run, with an aggregated price target of $38.24 implying a 7.8 percent upside.
This bullish sentiment was echoed by analysts. The 12-month consensus analyst price target is currently at $41.50, implying a strong upside.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
